Pradipsinh K. Rathod

Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.

David M. Shackleford, Francisco-Javier Gamo, Xiaoyi Deng, 2011, Journal of medicinal chemistry.

Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.

P. Rathod, John White, J. Baldwin, 2008, Journal of medicinal chemistry.

Shotgun DNA microarrays and stage‐specific gene expression in Plasmodium falciparum malaria

P. Brown, J. Derisi, P. Rathod, 2000, Molecular microbiology.